What Are Mystical Experiences and Why Do They Predict Therapeutic Outcomes?
One of the most consistent and puzzling findings in psilocybin research is that the intensity of mystical-type experiences during a session is one of the strongest predictors of therapeutic benefit — for depression, addiction, anxiety, and existential distress. This raises a question that researchers have been grappling with: what are mystical experiences, and why would they mediate therapeutic change?
Defining the Mystical Experience
The term "mystical experience" was operationalized for psilocybin research by drawing on the work of Walter Stace, William James, and Abraham Maslow. The Mystical Experience Questionnaire (MEQ), used in most Hopkins and NYU trials, measures seven components:
- Unity: Sense of all things being unified; loss of separation between self and world
- Noetic quality: The experience feels like genuine knowledge or insight, not just emotion
- Sacredness: A sense of reverence or holiness about the experience
- Deeply felt positive mood: Profound joy, peace, love
- Transcendence of time and space: Sense of existing outside normal temporal/spatial limits
- Paradoxicality: Awareness that the experience is both ineffable and real, both everything and nothing
- Ineffability: Difficulty putting the experience into words
A "complete mystical experience" by Hopkins criteria requires scoring above threshold on all seven components. In psilocybin trials, roughly 50-80% of participants at high doses report complete mystical experiences.
The Predictive Finding
The Hopkins smoking cessation trial (Garcia-Romeu et al., 2014) found that the degree of mystical experience intensity predicted smoking abstinence at 6-month follow-up. Participants who had more complete mystical experiences were more likely to have quit smoking. This was not explained by dose alone — two people at the same dose could have different mystical experience intensity and different outcomes.
The Hopkins depression trial found similar patterns: mystical experience intensity was a significant predictor of antidepressant response at 4-week follow-up. PTSD trials and anxiety trials have shown related patterns.
This creates an interesting mechanistic question: what is it about the mystical experience that produces therapeutic change?
Proposed Mechanisms
Changed relationship with self: The core of the mystical experience is often described as the dissolution of the sense of self as a separate, isolated entity. For many mental health conditions, the pathological state involves rigid, ruminative, self-focused thinking. A mystical experience that temporarily dissolves the self-as-separate may break the rigid self-narrative that depression, addiction, and anxiety depend on.
Meaning-making: The "noetic quality" of mystical experiences — the sense that what was experienced was genuinely true and important — appears to support lasting belief change. People who have mystical experiences in psilocybin sessions frequently describe permanent shifts in how they understand themselves, their place in the world, and what matters to them. These meaning shifts appear to be therapeutic when they involve reduced self-judgment, increased compassion, and changed priorities.
Awe and self-transcendence: Psychological research on awe shows that experiences of vastness and self-transcendence reduce self-focused thinking, increase prosocial motivation, and reduce death anxiety. These effects overlap with the therapeutic targets of psilocybin.
Biological correlate: At the neural level, mystical experiences during psilocybin correlate with maximal disruption of the default mode network — the network associated with self-referential thought. The brain-wide entropy increase and cross-network connectivity that characterize deep psilocybin states may be the biological substrate of the self-transcendence phenomenology.
The Research Design Implication
The mystical experience finding has significantly shaped how psilocybin therapy is designed. Rather than treating psilocybin as a pharmacological antidepressant that works like an SSRI (drug → symptom reduction), Hopkins and NYU protocols treat the session as a psychologically meaningful event that requires preparation, facilitation, and integration.
This means:
- Preparation sessions help orient the participant toward openness, surrender, and meaning-making — conditions that support mystical experience
- Music is carefully selected to guide the emotional arc of the session and support peak experiences
- The "Trust, Let Go, Be Open" instruction is given to participants — a cue toward surrendering to rather than resisting the experience, which is correlated with mystical experience intensity
- Integration sessions are designed to help participants process and apply what the mystical experience revealed
The drug alone, without this context, appears substantially less therapeutic.
The Skeptical View
Not all researchers accept the mystical experience framing as mechanistically central. Alternative interpretations:
- The MEQ may measure general positive affect and depth of experience rather than specifically "mystical" states — it's possible what it's capturing is simply "how intense and positive was this session"
- Expectancy effects may inflate MEQ scores (people who expect mystical experiences report them more readily)
- The noetic quality — the sense of genuine insight — may reflect post-hoc meaning-making rather than the experience itself
These critiques don't eliminate the predictive finding, but they complicate the interpretation. Whether what matters is "mystical experience" specifically or simply "deeply meaningful, positive, intense session" remains an open research question.
What This Means Practically
For anyone considering psilocybin therapy, the mystical experience finding suggests:
- Depth matters: Sessions oriented toward openness and depth — not control or ego protection — are more predictive of therapeutic benefit
- The frightening parts may be therapeutic: Difficult material encountered during a session (grief, fear, existential confrontation) often precedes the most meaningful breakthroughs
- Resistance works against the outcome: The tendency to mentally resist or fight difficult material during a session is correlated with less mystical experience and less therapeutic benefit
- Context is not incidental: The therapeutic context (preparation, facilitation, integration) is part of what enables mystical experience, not a peripheral add-on